Drugs like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are now mainstream, with patients often asking about them before clinicians bring them up
One comprehensive study on this mode is The STEP 1 trial, a randomized, double-blind study published in The New England Journal of Medicine
This ensures your treatment plan, including dosing schedules and injection guidance, is tailored specifically to you
Device In the US, Wegovy is available as single-dose autoinjector for both reimbursed and self-pay users, while Zepbound offers vials for self-pay and higher-priced autoinjectors for reimbursed segments
As a primary care and functional medicine physician with a specialty in perimenopause and menopause, Ive watched the growing interest in GLP-1 medications for weight management during perimenopause with both excitement and caution